Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 148INDUSTRY 61OTHER_GOV 11NIH 3UNKNOWN 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 36Stomach Neoplasms 19Esophageal Neoplasms 17Carcinoma, Non-Small-Cell Lung 13Colorectal Neoplasms 12Rectal Neoplasms 11Triple Negative Breast Neoplasms 9Lung Neoplasms 8Brain Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasms 6Neoplasm Metastasis 6Esophageal Squamous Cell Carcinoma 6Nasopharyngeal Carcinoma 5Melanoma 4Lymphoma, Extranodal NK-T-Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Recurrence 3Meningeal Carcinomatosis 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Colonic Neoplasms 3Vomiting 2Urinary Bladder Neoplasms 2Skin Diseases 2Sarcoma 2

Interventions

nabiximols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Cancer Pain × Clear all
NCT01262651 2018-04-23

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

GWPharm

Phase 3 Completed
397 enrolled 18 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡